The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) with oral selinexor plus low dose dexamethasone (Sd) in patients with triple class refractory-multiple myeloma (TCR-MM).
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Takeda
Research Funding - Celgene; Takeda
 
Sundar Jagannath
Honoraria - Celgene; Karyopharm Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst)
 
Ajai Chari
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Array Biopharma; Bayer; Celgene; Janssen Oncology; Millennium; Novartis; Seagen
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Bristol-Myers Squibb (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda
 
Dan T. Vogl
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Teva
Research Funding - Acetylon Pharmaceuticals (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Millennium (Inst)
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
David Dingli
Honoraria - Alexion Pharmaceuticals; Janssen; Rigel
Consulting or Advisory Role - Millenium Pharamceuticals; Takeda
Research Funding - Juno Therapeutics
 
L J Wei
No Relationships to Disclose
 
Lingling Li
Employment - Karyopharm Therapeutics; Sanofi (I)
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Shijie Tang
Employment - Karyopharm Therapeutics; Moderna Therapeutics (I)
Stock and Other Ownership Interests - Karyopharm Therapeutics; Moderna Therapeutics (I)
 
William Reichman
Employment - ARIAD; Karyopharm Therapeutics; Takeda
Stock and Other Ownership Interests - ARIAD; Karyopharm Therapeutics
 
Michael G. Kauffman
Employment - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
Leadership - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
Stock and Other Ownership Interests - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
 
Jatin J. Shah
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Sharon Shacham
Employment - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
Leadership - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
Stock and Other Ownership Interests - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics; Karyopharm Therapeutics (I)
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda